V
Venu G. Pillarisetty
Researcher at University of Washington
Publications - 84
Citations - 4203
Venu G. Pillarisetty is an academic researcher from University of Washington. The author has contributed to research in topics: Immune system & Immunotherapy. The author has an hindex of 31, co-authored 70 publications receiving 3210 citations. Previous affiliations of Venu G. Pillarisetty include University of Washington Medical Center & Fred Hutchinson Cancer Research Center.
Papers
More filters
Journal ArticleDOI
Neuroendocrine tumors, version 1.2015
Matthew H. Kulke,Manisha H. Shah,Al B. Benson,Emily K. Bergsland,Jordan Berlin,Lawrence S. Blaszkowsky,Lyska Emerson,Paul F. Engstrom,Paul T. Fanta,Thomas J. Giordano,Whitney S. Goldner,Thorvardur R. Halfdanarson,Martin J. Heslin,Fouad Kandeel,Pamela L. Kunz,Boris W. Kuvshinoff,Christopher H. Lieu,Jeffrey F. Moley,Gitonga Munene,Venu G. Pillarisetty,Leonard B. Saltz,Julie Ann Sosa,Jonathan R. Strosberg,Jean Nicolas Vauthey,Christopher L. Wolfgang,James C. Yao,Jennifer L. Burns,Deborah A. Freedman-Cass +27 more
TL;DR: These guidelines focus on sporadic NETs of the pancreas, gastrointestinal tract, lung, and thymus, which are associated with symptoms attributable to hormonal hypersecretion.
Journal ArticleDOI
γδ T Cells Support Pancreatic Oncogenesis by Restraining αβ T Cell Activation
Donnele Daley,Constantinos P. Zambirinis,Lena Seifert,Neha Akkad,Navyatha Mohan,Gregor Werba,Rocky Barilla,Alejandro Torres-Hernandez,Mautin Hundeyin,Vishnu R. Mani,Antonina Avanzi,Daniel Tippens,Rajkishen Narayanan,Jung Eun Jang,Elliot Newman,Venu G. Pillarisetty,Michael L. Dustin,Michael L. Dustin,Dafna Bar-Sagi,Cristina H. Hajdu,George Miller +20 more
TL;DR: Greek γδT cells are described as central regulators of effector T cell activation in cancer via novel cross-talk and are identified as critical sources of immune-suppressive checkpoint ligands in PDA.
Journal ArticleDOI
Biopolymers codelivering engineered T cells and STING agonists can eliminate heterogeneous tumors
Tyrel T. Smith,Howell F. Moffett,Sirkka B. Stephan,Cary F. Opel,Amy Dumigan,Xiuyun Jiang,Venu G. Pillarisetty,Smitha P. S. Pillai,K. Dane Wittrup,Matthias Stephan,Matthias Stephan +10 more
TL;DR: It is found that CAR T cells can migrate from biopolymer scaffolds and eradicate tumors more effectively than does systemic delivery of the same cells and codelivery of stimulator of IFN genes (STING) agonists stimulates immune responses to eliminate tumor cells that are not recognized by the adoptively transferred lymphocytes.
Journal ArticleDOI
Management of Recurrent Retroperitoneal Sarcoma (RPS) in the Adult: A Consensus Approach from the Trans-Atlantic RPS Working Group
J. Ahlen,Nita Ahuja,R. Antbacka,Sanjay P. Bagaria,J.-Y. Blay,S. Bonvalot,Dario Callegaro,Robert J. Canter,Kenneth Cardona,Paolo G. Casali,Chiara Colombo,A. P. Dei Tos,A. De Paoli,Anant Desai,Brendan C. Dickson,Fritz C. Eilber,M. Fiore,Christopher D.M. Fletcher,Samuel J Ford,Hans Gelderblom,Ricardo J. Gonzalez,Giovanni Grignani,Grignol,Alessandro Gronchi,R. L. Haas,Andrew J. Hayes,Wolfgang Hartmann,T. Henzler,Peter Hohenberger,Antoine Italiano,Jens Jakob,Robin L. Jones,Ian Judson,John M. Kane,Guy Lahat,Andrea MacNeill,Roberta Maestro,Christina Messiou,Pierre Meeus,Rosalba Miceli,John T. Mullen,Carolyn Nessim,Elisabetta Pennacchioli,Venu G. Pillarisetty,Raphael E. Pollock,Quagliuolo,Stefano Radaelli,Chandrajit P. Raut,Piotr Rutkowski,Sergio Sandrucci,Yvonne Schrage,Jason K. Sicklick,Myles Smith,Silvia Stacchiotti,Eberhard Stoeckle,Dirk C. Strauss +55 more
TL;DR: In this paper, a transatlantic working group was established to share institutional experiences, build large multi-institutional case series, and develop consensus documents on the approach to recurrent soft tissue sarcomas.
Journal ArticleDOI
Liver dendritic cells are less immunogenic than spleen dendritic cells because of differences in subtype composition
TL;DR: The findings support the widely held notion that liver DC are generally weak activators of immunity, although they are capable of producing inflammatory cytokines, and certain subtypes potently activate T cells.